Browsing by Author Mcnally, J

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 5 of 5
TitleAuthor(s)Issue Date
 
Deferred treatment with a fixed‐dose combination of sofosbuvir‐velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection
Journal:Journal of Viral Hepatitis
Asselah, TShafran, SDBourgeois, SLai, CLMathurin, PWillems, BNguyen, MHDavis, MNHuang, KCSvarovskaia, EOsinusi, AMcNally, JBrainard, DMShaikh, OSTran, TT
2019
 
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
Journal:New England Journal of Medicine
Feld, JJJacobson, IMHézode, CAsselah, TRuane, PJGruener, NAbergel, AMangia, ALai, CLChan, HLYMazzotta, FMoreno, CYoshida, EShafran, SDTowner, WJTran, TTMcNally, JOsinusi, ASvarovskaia, EZhu, YBrainard, DMMcHutchison, JGAgarwal, KZeuzem, S
2015
 
Sofosbuvir/velpatasvir (SOF/VEL) for 12 weeks in genotype 1, 2, 4, 5, 6 HCV patients: ASTRAL-1 study
Proceeding/Conference:Hepatology International
Chan, HLYFeld, JJAgarwal, KHezode, CAsselah, TRuane, PJGruener, NAbergel, AMangia, ALai, CLMazzotta, FMoreno, CYoshida, EShafran, SDTowner, WJTran, TTMcNally, JBrainard, DMJacobson, IMZeuzem, S
2016
 
Sofosbuvir/Velpatasvir fixed dose combination for 12 weeks in hcv infected patients previously treated with placebo: results of the deferred treatment study (GS-US-342-1446 Study)
Proceeding/Conference:Journal of Hepatology
Asselah, TShafran, SBourgeois, SLai, CLCramp, MMathurin, PWillems, BNguyen, MHDavis, MNHuang, KCSvarovskaia, EOsinusi, AMcnally, JBrainard, DMcHutchison, JShaikh, OSTran, TT
2016
 
Sofosbuvir/velpatasvir for 12 weeks results in high SVR12 rates with a favorable safety profile in asian patients: an integrated subgroup analysis of the ASTRAL-1, ASTRAL-2, and ASTRAL-3 studies
Proceeding/Conference:Hepatology International
Chan, HLYLai, CLFeld, JReau, NHan, LMcNabb, BLMcNally, JBrainard, DMFoster, GRoberts, S
2017
Showing results 1 to 5 of 5